Print Page   |   Contact Us   |   Sign In   |   Join ISBER
Biopreservation and Biobanking (BIO)

Biopreservation and Biobanking, ISBER's Official Journal



Biopreservation and Biobanking (BIO) is the first journal to provide a unifying forum for the peer-reviewed communication of recent advances in the emerging and evolving field of biospecimen procurement, processing, preservation, and banking. The Journal publishes a range of original articles focusing on current challenges and problems related to the processing of macromolecules, cells, and tissues. It also explores the ethical, legal, and societal considerations surrounding biobanking and biorepository operation.

ISBER members may choose to receive access to BIO as a membership benefit. To learn more about ISBER memberships, click here


Note on Fall Membership Renewal & Journal Access:

New and renewing members who sign up for the printed-and-online journal membership option in the preceding fall will have access to all issues of the online journal, but will not receive that year's remaining print issues. If they so wish, they could purchase the entire year's volume and all issues from that year will be sent, including back issues.


Biopreservation and Biobanking coverage includes:

  • Systems preservation
  • Preservation states
  • Cellular and molecular mechanisms
  • Preservation engineering-bioprocessing
  • Stem cell biobanking
  • Optimization protocols-biopackaging
  • Best practices
  • Natural systems models
  • Biosafety
  • Ethical/legal/regulatory considerations/societal issues


We are pleased to share the following information and dedicated website with our partners and colleagues. As an academic publisher, we publish many important resources relevant to COVID-19 such as Health SecurityViral ImmunologyTelemedicine and e-Health, and Vector Borne and Zoonotic Diseases. We are keeping our finger on the pulse of the spread of COVID-19 around the world and have taken the opportunity to provide free access to all papers within our portfolio relevant coronavirus research in hopes that it can be a useful resource in developing and implementing a successful vaccine. Here is a direct link to access all coronavirus-related research within the Liebert portfolio:

ISBER Head Office, 750 Pender Street, Suite 301, Vancouver, BC V6C 2T7, Canada.   
T: 1-604-484-5693 F: 1-604-874-4378 E: 

©2018 International Society for Biological and Environmental Repositories (ISBER). All rights reserved.
Facebook GooglePlus Twitter